91 related articles for article (PubMed ID: 6129983)
1. The purported dopamine agonist (3,4-dihydroxyphenylimino)-2-imidazolidine (DPI) acts as a nonselective alpha-adrenoceptor agonist in inducing hypertension, hypomotility and hypothermia in the rat.
Van Oene JC; Houwing HA; Horn AS
Eur J Pharmacol; 1982 Nov; 85(1):69-77. PubMed ID: 6129983
[TBL] [Abstract][Full Text] [Related]
2. Evidence that the purported dopaminergic agonist (3,4-dihydroxyphenylimino)-2-imidazolidine (DPI) may reduce rat striatal dopamine turnover by an alpha 2-adrenergic mechanism.
van Oene JC; Houwing HA; Horn AS
Eur J Pharmacol; 1982 Jun; 81(1):75-87. PubMed ID: 6126370
[TBL] [Abstract][Full Text] [Related]
3. The purported dopamine agonist DPI inhibits [3H]noradrenaline release from rat cortical slices but not [3H]dopamine and [14C]acetylcholine release from rat striatal slices in-vitro.
Van Oene JC; Sminia P; Mulder AH; Horn AS
J Pharm Pharmacol; 1983 Dec; 35(12):786-92. PubMed ID: 6141240
[TBL] [Abstract][Full Text] [Related]
4. The pharmacological characterization of 3,4-dihydroxyphenylimino-2-imidazolidine (DPI) as a potent mixed alpha 1/alpha 2-adrenoceptor agonist rather than as a dopamine receptor agonist.
van Oene JC; Horn AS
J Pharm Pharmacol; 1985 Nov; 37(11):844-7. PubMed ID: 2867175
[No Abstract] [Full Text] [Related]
5. 3,4-disubstituted phenyliminoimidazolidines as potential prodrugs of the purported dopamine agonist 3,4-dihydroxyphenylimino-2-imidazolidine (DPI).
Houwing HA; van Oene JC; Horn AS
Pharm Weekbl Sci; 1983 Aug; 5(4):177-81. PubMed ID: 6622213
[TBL] [Abstract][Full Text] [Related]
6. Agonistic actions of DPI (2-(3,4-dihydroxyphenylimino)-imidazolidine) on alpha-adrenoceptors and dopamine receptors.
Woodman OL; Medgett IC; Lang WJ; Rand MJ
Eur J Pharmacol; 1981 Oct; 75(1):11-9. PubMed ID: 6119208
[TBL] [Abstract][Full Text] [Related]
7. Differential effect of calcium entry blockers on alpha 1-adrenoceptor-mediated vasoconstriction in vivo.
Timmermans PB; Mathy MJ; Wilffert B; Kalkman HO; Thoolen MJ; de Jonge A; van Meel JC; van Zwieten PA
Naunyn Schmiedebergs Arch Pharmacol; 1983 Dec; 324(4):239-45. PubMed ID: 6141529
[TBL] [Abstract][Full Text] [Related]
8. Effects of DPI (2-(3,4-dihydroxyphenylimino)-imidazolidine) on prejunctional alpha-adrenoceptors and prejunctional dopamine receptors in the rabbit ear artery.
Medgett IC
Naunyn Schmiedebergs Arch Pharmacol; 1983 Jun; 323(2):141-4. PubMed ID: 6136918
[TBL] [Abstract][Full Text] [Related]
9. (3,4-Dihydroxyphenylimino)-2-imidazoline (DPI) and its action at noradrenergic and dopaminergic receptors in the nucleus accumbens of rats: mesolimbic catecholamine receptors and hyperactivity.
Cools AR; Oosterloo SK
J Neural Transm Suppl; 1983; 18():181-8. PubMed ID: 6308148
[TBL] [Abstract][Full Text] [Related]
10. The thermogenic actions of alpha 2-adrenoceptor agonists in reserpinized mice are mediated via a central postsynaptic alpha 2-adrenoceptor mechanism.
Bill DJ; Hughes IE; Stephens RJ
Br J Pharmacol; 1989 Jan; 96(1):133-43. PubMed ID: 2564288
[TBL] [Abstract][Full Text] [Related]
11. Effects of PN 200-110, a new calcium antagonist, on alpha 1- and alpha 2-adrenoceptor mediated vasoconstriction elicited by selective alpha-adrenoceptor agonists and catecholamines in the pithed rat.
Jie K; van Brummelen P; Timmermans PB; Thoolen MJ; van Zwieten PA
Arch Int Pharmacodyn Ther; 1985 Nov; 278(1):72-86. PubMed ID: 2869738
[TBL] [Abstract][Full Text] [Related]
12. (3,4-Dihydroxyphenylimino)-2-imidazoline (DPI): a stimulant of alpha-adrenoceptors and dopamine receptors.
Struyker-Boudier HA; Cools AR
J Pharm Pharmacol; 1984 Dec; 36(12):859-60. PubMed ID: 6151987
[No Abstract] [Full Text] [Related]
13. Evidence for a role of the shell of the nucleus accumbens in oral behavior of freely moving rats.
Prinssen EP; Balestra W; Bemelmans FF; Cools AR
J Neurosci; 1994 Mar; 14(3 Pt 2):1555-62. PubMed ID: 7907364
[TBL] [Abstract][Full Text] [Related]
14. Interaction between the inhibitory action of acetylcholine and the alpha-adrenoceptor autoinhibitory feedback system on release of [3H]-noradrenaline from rat atria and rabbit ear artery.
Loiacono RE; Rand MJ; Story DF
Br J Pharmacol; 1985 Mar; 84(3):697-705. PubMed ID: 2859064
[TBL] [Abstract][Full Text] [Related]
15. Interaction between the calcium entry blocker nifedipine with the alpha 1-adrenoreceptor-mediated increase in diastolic pressure elicited by catecholamines.
Wilffert B; Davidesko D; De Jonge A; Thoolen MJ; Timmermans PB; Van Zwieten PA
J Auton Pharmacol; 1984 Jun; 4(2):87-92. PubMed ID: 6146625
[TBL] [Abstract][Full Text] [Related]
16. d-Sulpiride inhibits oral behaviour elicited from the nucleus accumbens of freely moving rats.
Prinssen EP; Heeren DJ; Cools AR
Brain Res Bull; 1996; 39(2):101-7. PubMed ID: 8846111
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms involved in the hyperglycemic response induced by clonidine and other alpha-2 adrenoceptor agonists.
DiTullio NW; Cieslinski L; Matthews WD; Storer B
J Pharmacol Exp Ther; 1984 Jan; 228(1):168-73. PubMed ID: 6141276
[TBL] [Abstract][Full Text] [Related]
18. DPI, a supposed selective agonist of inhibitory dopamine receptors, strongly increases rat diuresis through alpha-adrenergic receptor activation.
Baggio G; Ferrari F
Life Sci; 1981 Mar; 28(13):1449-56. PubMed ID: 6113526
[No Abstract] [Full Text] [Related]
19. Effects of 7-hydroxy-N,N-di-n-propylaminotetralin on behaviour and blood pressure of spontaneously hypertensive rats.
Van den Buuse M
Eur J Pharmacol; 1993 Oct; 243(2):169-77. PubMed ID: 8276066
[TBL] [Abstract][Full Text] [Related]
20. Characterisation of the mechanisms by which purported dopamine agonists reduce spontaneous locomotor activity of mice.
Costall B; Lim SK; Naylor RJ
Eur J Pharmacol; 1981 Jul; 73(2-3):175-88. PubMed ID: 6118281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
